Literature DB >> 23112754

Shared Copy Number Variation in Simultaneous Nephroblastoma and Neuroblastoma due to Fanconi Anemia.

A Serra1, K Eirich, A K Winkler, K Mrasek, G Göhring, G Barbi, H Cario, B Schlegelberger, B Pokora, T Liehr, C Leriche, D Henne-Bruns, T F Barth, D Schindler.   

Abstract

Concurrent emergence of nephroblastoma (Wilms Tumor; WT) and neuroblastoma (NB) is rare and mostly observed in patients with severe subtypes of Fanconi anemia (FA) with or without VACTER-L association (VL). We investigated the hypothesis that early consequences of genomic instability result in shared regions with copy number variation in different precursor cells that originate distinct embryonal tumors. We observed a newborn girl with FA and VL (aplasia of the thumbs, cloacal atresia (urogenital sinus), tethered cord at L3/L4, muscular ventricular septum defect, and horseshoe-kidney with a single ureter) who simultaneously acquired an epithelial-type WT in the left portion of the kidney and a poorly differentiated adrenal NB in infancy. A novel homozygous germline frameshift mutation in PALB2 (c.1676_c1677delAAinsG) leading to protein truncation (pGln526ArgfsX1) inherited from consanguineous parents formed the genetic basis of FA-N. Spontaneous and induced chromosomal instability was detected in the majority of cells analyzed from peripheral lymphocytes, bone marrow, and cultured fibroblasts. Bone marrow cells also showed complex chromosome rearrangements consistent with the myelodysplastic syndrome at 11 months of age. Array-comparative genomic hybridization analyses of both WT and NB showed shared gains or amplifications within the chromosomal regions 11p15.5 and 17q21.31-q25.3, including genes that are reportedly implicated in tumor development such as IGF2, H19, WT2, BIRC5, and HRAS.

Entities:  

Year:  2012        PMID: 23112754      PMCID: PMC3473353          DOI: 10.1159/000341935

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  43 in total

1.  A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line.

Authors:  M Raghunath; R Patti; P Bannerman; C M Lee; S Baker; L N Sutton; P C Phillips; C Damodar Reddy
Journal:  Brain Res Mol Brain Res       Date:  2000-05-05

2.  EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.

Authors:  Chunxi Wang; Zhihui Liu; Chan-Wook Woo; Zhijie Li; Lifeng Wang; Jun S Wei; Victor E Marquez; Susan E Bates; Qihuang Jin; Javed Khan; Kai Ge; Carol J Thiele
Journal:  Cancer Res       Date:  2011-11-08       Impact factor: 12.701

3.  Altered expression of imprinted genes in Wilms tumors.

Authors:  Jochen Hubertus; Martin Lacher; Marietta Rottenkolber; Josef Müller-Höcker; Michael Berger; Maximilian Stehr; Dietrich von Schweinitz; Roland Kappler
Journal:  Oncol Rep       Date:  2010-12-20       Impact factor: 3.906

4.  Multiple synchronous tumors in a child with Fanconi anemia.

Authors:  Alessia Compostella; Tiziana Toffolutti; Pietro Soloni; Patrizia Dall'Igna; Modesto Carli; Gianni Bisogno
Journal:  J Pediatr Surg       Date:  2010-02       Impact factor: 2.545

5.  Esophageal stenosis in a child presenting a de novo 7q terminal deletion.

Authors:  Paulo R G Zen; Mariluce Riegel; Rafael F M Rosa; Louise L C Pinto; Carla Graziadio; Ida V D Schwartz; Giorgio A Paskulin
Journal:  Eur J Med Genet       Date:  2010-06-22       Impact factor: 2.708

6.  Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.

Authors:  Mariko D Dewire; David W Ellison; Zoltan Patay; Peter J McKinnon; Robert P Sanders; Amar Gajjar
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

7.  Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas.

Authors:  A Leone; R C Seeger; C M Hong; Y Y Hu; M J Arboleda; G M Brodeur; D Stram; D J Slamon; P S Steeg
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

8.  Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

Authors:  Brigitte Royer-Pokora; Maike Busch; Manfred Beier; Constanze Duhme; Carmen de Torres; Jaume Mora; Artur Brandt; Hans-Dieter Royer
Journal:  Hum Mol Genet       Date:  2010-01-27       Impact factor: 6.150

9.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

Authors:  Hester J T van Zeeburg; Peter J F Snijders; Thijs Wu; Eliane Gluckman; Jean Soulier; Jordi Surralles; Maria Castella; Jacqueline E van der Wal; Johan Wennerberg; Joseph Califano; Eunike Velleuer; Ralf Dietrich; Wolfram Ebell; Elisabeth Bloemena; Hans Joenje; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

10.  Disabled-1 alternative splicing in human fetal retina and neural tumors.

Authors:  Sachin Katyal; Darryl D Glubrecht; Lei Li; Zhihua Gao; Roseline Godbout
Journal:  PLoS One       Date:  2011-12-06       Impact factor: 3.240

View more
  5 in total

Review 1.  A Comprehensive Review of Pediatric Tumors and Associated Cancer Predisposition Syndromes.

Authors:  Sarah Scollon; Amanda Knoth Anglin; Martha Thomas; Joyce T Turner; Kami Wolfe Schneider
Journal:  J Genet Couns       Date:  2017-03-29       Impact factor: 2.537

2.  The Cellular and Molecular Landscape of Synchronous Pediatric Sialoblastoma and Hepatoblastoma.

Authors:  Ran Yang; Yong Zhan; Yi Li; Shu-Yang Dai; Shi-Wei He; Chun-Jing Ye; Ling-Du Meng; De-Qian Chen; Chen-Bin Dong; Lian Chen; Gong Chen; Kui-Ran Dong; Kai Li; Shan Zheng; Jun Li; Wei Yao; Rui Dong
Journal:  Front Oncol       Date:  2022-07-04       Impact factor: 5.738

3.  A Hypomorphic PALB2 Allele Gives Rise to an Unusual Form of FA-N Associated with Lymphoid Tumour Development.

Authors:  Philip J Byrd; Grant S Stewart; Anna Smith; Charlotte Eaton; Alexander J Taylor; Chloe Guy; Ieva Eringyte; Peggy Fooks; James I Last; Robert Horsley; Antony W Oliver; Dragana Janic; Lidija Dokmanovic; Tatjana Stankovic; A Malcolm R Taylor
Journal:  PLoS Genet       Date:  2016-03-18       Impact factor: 5.917

4.  Synchronous Ipsilateral Wilms' Tumor and Neuroblastoma in an Infant.

Authors:  Yogesh Kumar Sarin; Nirali Chirag Thakkar; Shalini Sinha
Journal:  APSP J Case Rep       Date:  2016-01-01

5.  Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of CHEK2 in Wilms tumour susceptibility.

Authors:  Sara Ciceri; Beatrice Gamba; Paola Corbetta; Patrizia Mondini; Monica Terenziani; Serena Catania; Marilina Nantron; Maurizio Bianchi; Paolo D'Angelo; Federica Torri; Fabio Macciardi; Paola Collini; Martina Di Martino; Fraia Melchionda; Andrea Di Cataldo; Filippo Spreafico; Paolo Radice; Daniela Perotti
Journal:  Oncotarget       Date:  2018-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.